Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to start review
Explore by Goal
"Be less curious about people and more curious about ideas."
- Marie Curie
Quick Explanation
Copied
Key claim (skeptical):
LJY-3-60 is proposed to be a monovalent molecular glue that templates CRBN homodimerization, driving CRBN autodegradation through the intrinsic CRL4–CRBN ubiquitin-proteasome machinery, without extrinsic E3 recruitment—supported by orthogonal cellular assays and an atomic-resolution co-crystal (CRBN Midi–LJY-3-60, 1.8 Å).
Mechanism is further motivated by a “degron mimicry” argument (structural similarity to the IKZF1 G-loop), plus SAR showing strict stereochemical requirements and insensitivity to some peripheral edits.
Evidence base comes from TR-FRET/NanoBRET occupancy, proteomics specificity, CRISPR dependency on UBE2D2, SEC/dimerization readouts, and pharmacology “off-switch” rescue experiments.
Background context (TPD & E3 ligase specificity):Targeted protein degradation strategies rely on E3-substrate recognition and (often) cooperative ternary complex formation; this paper’s claimed “reprogramming” of an E3 to self-destroy fits the broader mechanistic landscape of TPD.
Long Explanation
Paper review: Molecular Glue-Induced Homodimerization Drives Targeted CRBN Autodegradation
Paper identifier: 10.64898/2026.03.08.710235 (dated March 10, 2026 in provided metadata).
Claimed core mechanismLJY-3-60 templates a CRBN homodimer (via a ligand-bridged C2-symmetric interface), enabling trans-autoubiquitination and rapid CRBN autodegradation via intrinsic CRL4–CRBN machinery.
Figure A — Potency of CRBN occupancy & engagement
Extracted from provided text: TR-FRET IC50 (binary binding) and NanoBRET IC50 (intracellular target engagement).
Figure B — Specificity and kinetics (qualitative, since only stated in text)
Provided excerpt states: LJY-3-60 causes unique proteome-wide downregulation of CRBN and detectable degradation within ~2 hours; rescue by CRBN competitor, neddylation inhibition, and proteasome inhibition.
Readout
What the paper reports
Interpretation (skeptical)
Global proteomics (MOLT-4)
CRBN is the sole significantly downregulated protein after LJY-3-60 treatment (1 µM, 6 h; n=3 biological replicates stated).
Strong on-target signature, but the “sole” phrasing is limited by proteomics detection thresholds and the experimental conditions used.
Western blot kinetics
CRBN depletion is dose-dependent and detectable as early as ~2 h.
Fast kinetics support direct UPS-linked degradation rather than slower transcriptional effects.
Pharmacological rescue
CRBN degradation is abrogated by: pomalidomide (CRBN competitor), MLN4924 (NEDD8-activating enzyme inhibitor), and bortezomib (proteasome inhibitor).
Triad strongly implicates occupancy→CRL4 neddylation→proteasome dependence. However, inhibitor off-target effects are always a residual concern without additional genetic controls.
Figure C — Mechanistic evidence for CRBN homodimerization & intrinsic machinery dependence
Generally abrogate productive degradation despite maintained occupancy for some analogs (as stated)
Figure E — Proposed “off-switch” pharmacology (quantitative extracted)
Provided text gives: CC-885 context rescue by LJY-3-60 with REC50 ≈ 60 nM. (Additional rescue is described for TEAD1 after PROTAC washout, but without extractable numeric values beyond stating washout rescue.)
Mechanistic plausibility check (what is solid vs what remains uncertain)
What looks strongly supported (from the paper text you provided)
On-target specificity at the level of major degradation:** proteomics claims “CRBN as the sole significantly downregulated protein,” plus Western blot UPS-dependent rescue (pomalidomide/MLN4924/bortezomib) and rapid kinetics. Caveat: “sole” is constrained by proteomics sensitivity and the chosen conditions.
Intrinsic machinery linkage:** CRISPR dependency enriches UBE2D2 with lack of extrinsic E3 enrichment, aligning with the claim that LJY-3-60 co-opts intrinsic CRL4–CRBN rather than recruiting a separate E3.
Dimerization readouts are multi-modal: FLAG-IP-MS enriches CRBN; SEC shows a compound-dependent peak shift consistent with a stable dimeric assembly; NanoBiT reports rapid homodimer formation; structural work provides an atomic model for a ligand-bridged interface.
Where skepticism is warranted
Proteomics “sole downregulated protein” wording can be misleading if low-abundance off-target degradation is below detection or if only a single time point is sampled. For CRBN-based glues, chemoproteomics studies broadly show that CRBN can recruit many proteins depending on glue chemistry and cellular context.
Cell-line and reporter-system dependence: eGFP-CRBN reporter screens and engineered CRBN Midi constructs improve tractability but can shift apparent biology vs fully endogenous stoichiometry and native CRBN complex context.
Over-inference risk from correlations: associating SEC/NanoBiT dimerization with trans-autoubiquitination is mechanistically plausible, but the text-provided excerpt doesn’t include direct ubiquitin-chain site mapping or temporal ordering experiments that definitively separate “dimer forms first” vs “autoubiquitination triggers dimer stabilization.”
Generalizability across E3 ligases: the paper frames a design framework for other E3s. However, this remains an extrapolation until similarly stringent mechanistic demonstrations exist for other E3s.
Data deposited / reproducibility checkpoints (from provided text)
Structure deposition: CRBN Midi–LJY-3-60 coordinates/structure factors are said to be deposited under PDB accession 22UL.
The paper claims a first-in-class modality where a monovalent molecular glue drives E3 self-destruction by templating CRBN homodimerization, supported by an atomic-resolution co-crystal structure (1.8 Å) and multilayer cellular/biophysical validation—an uncommon mechanism relative to the typical neo-substrate recruitment paradigm described broadly in TPD literature.
Scientific Quality
90%
High internal coherence: multiple orthogonal assay classes (occupancy, proteomics specificity, genetic dependency, interactomics, SEC/NanoBiT dimerization, co-crystallography, SAR, and pharmacological rescue/off-switch). Main reproducibility gap from the provided text: lack of raw proteomics/screen datasets and full methods details beyond what’s excerpted. Interpretation risk remains for any claim of “sole” specificity due to detection limits and single-cell-line condition dependence.
Study Generality
80%
Mechanistically general as a design principle (degron-mimicry templating proximity to enable trans-autoubiquitination), but experimental generality is largely demonstrated for one E3 adapter system (CRBN) in specific human cell contexts; cross-E3 translation is plausible yet not directly proven in the provided text.
Study Usefulness
90%
Provides both (i) a mechanistic blueprint for constructing self-destructive E3 modifiers and (ii) a potential chemical tool to temporally modulate CRBN levels as a control/off-switch in CRBN-dependent TPD settings—useful for target validation and safety engineering workflows in principle.
Study Reproducibility
80%
A key structural anchor (PDB 22UL) is deposited per provided metadata, and the described experimental logic is standard in the field (TR-FRET, NanoBRET, SEC, NanoBiT, CRISPR screens, proteomics, WB). However, the provided text does not specify public deposition of raw omics/screen data, limiting full reproducibility assessment from the excerpt alone.
Explanatory Depth
90%
Depth is high because the paper links (a) cell-level dependencies and UPS inhibitors, (b) dimerization readouts, and (c) an explicit ligand-bridged homodimer structure with proposed interfacial contacts and degron mimicry logic.
It is currently not applicable: the provided content contains no sequence/omics matrices to ingest for computational reanalysis beyond plotting extracted IC50/REC50 values already visualized from text.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The claim that extrinsic E3 recruitment is absent could be wrong if a low-abundance or transient partner E3 is not captured by the interactome readout used; the homodimer model would then be a downstream consequence rather than the initiating step.
The ‘degron mimicry of IKZF1 G-loop’ could be a structural coincidence; if mutating the predicted ligand–residue hydrogen bond network does not abolish dimerization, the mimicry narrative would weaken even if autodegradation persists via another interface logic.
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
Keep Exploring
